MATINAS BIOPHARMA HOLDINGS, INC. Gain (Loss) on Termination of Lease
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Gain (Loss) on Termination of Lease of $368.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on termination of lease for the quarter ending 2026-06-30 was $368.00K.
| Period end | Gain (Loss) on Termination of Lease | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month |
|---|---|---|---|
| 2026-06-30 | $368.00K 10-Q · filed 2026-08-13 | $368.00K 10-Q · filed 2026-08-13 | |
| 2026-04-29 | $368.00K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |